N1-((S)-3-(1H-Indol-3-yl)-1-(((R)-3-methyl-1-((3aR,4R,6R,7aS)-5,5,7a-trimethylhexahydro-4,6-methanobenzo[d][1,3,2]dioxaborol-2-yl)butyl)amino)-1-oxopropan-2-yl)-N4-hydroxyterephthalamide

ID: ALA4547369

PubChem CID: 155553474

Max Phase: Preclinical

Molecular Formula: C34H43BN4O6

Molecular Weight: 614.55

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)c1ccc(C(=O)NO)cc1)B1O[C@@H]2[C@@H]3C[C@H](C[C@]2(C)O1)C3(C)C

Standard InChI:  InChI=1S/C34H43BN4O6/c1-19(2)14-28(35-44-29-25-16-23(33(25,3)4)17-34(29,5)45-35)38-32(42)27(15-22-18-36-26-9-7-6-8-24(22)26)37-30(40)20-10-12-21(13-11-20)31(41)39-43/h6-13,18-19,23,25,27-29,36,43H,14-17H2,1-5H3,(H,37,40)(H,38,42)(H,39,41)/t23-,25+,27+,28+,29-,34+/m1/s1

Standard InChI Key:  QETSGGARENBKCB-FJPRILFMSA-N

Molfile:  

 
     RDKit          2D

 48 53  0  0  0  0  0  0  0  0999 V2000
   15.3327  -27.5327    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.6269  -27.9455    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.3372  -28.3503    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1607  -29.3363    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8684  -28.9236    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.5762  -29.3363    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.8684  -28.1064    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.2839  -28.9236    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.9916  -29.3363    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.6993  -28.9236    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.9916  -30.1535    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.4070  -29.3363    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.1147  -28.9236    0.0000 B   0  0  0  0  0  0  0  0  0  0  0  0
   12.8618  -29.2554    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.2007  -28.1062    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.9999  -27.9403    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.4049  -28.6489    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.2165  -28.6526    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.2244  -27.2365    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.4066  -27.2312    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.5839  -27.2232    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.8056  -29.3528    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   13.8015  -27.9702    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.6391  -26.5365    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   14.6309  -29.3527    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   11.4070  -30.1535    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.1147  -30.5621    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.1147  -31.3793    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.8224  -30.1535    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2839  -28.1064    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.9916  -27.6978    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.7344  -28.0285    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2812  -27.4213    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.4499  -28.9269    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7427  -29.3389    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7458  -30.1591    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4621  -30.5654    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1664  -30.1510    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0404  -30.5717    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3304  -30.1671    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.0451  -31.3888    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.0733  -26.8835    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8736  -26.7173    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1283  -25.9426    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5838  -25.3407    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7812  -25.5085    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.5227  -26.2802    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6250  -30.5797    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  2  1  0
  4  5  1  0
  5  6  1  0
  5  7  2  0
  6  8  1  0
  8  9  1  0
  9 10  1  0
  9 11  2  0
 10 12  1  0
 12 13  1  0
 13 14  1  0
 14 17  1  0
 16 15  1  0
 15 13  1  0
 16 17  1  0
 16 20  1  0
 17 18  1  0
 18  2  1  0
  2 19  1  0
 19 20  1  0
 16 21  1  6
 17 22  1  6
 18 23  1  0
 23 19  1  0
 19 24  1  1
 18 25  1  1
 12 26  1  6
 26 27  1  0
 27 28  1  0
 27 29  1  0
  8 30  1  1
 30 31  1  0
 31 32  2  0
 32 33  1  0
 33 43  1  0
 42 31  1  0
  4 34  2  0
 34 35  1  0
 35 36  2  0
 36 37  1  0
 37 38  2  0
 38  4  1  0
 36 39  1  0
 39 40  1  0
 39 41  2  0
 42 43  2  0
 43 44  1  0
 44 45  2  0
 45 46  1  0
 46 47  2  0
 47 42  1  0
 40 48  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4547369

    ---

Associated Targets(Human)

HDAC1 Tclin Histone deacetylase (HDAC1 and HDAC2) (618 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 614.55Molecular Weight (Monoisotopic): 614.3276AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Zhou Y, Liu X, Xue J, Liu L, Liang T, Li W, Yang X, Hou X, Fang H..  (2020)  Discovery of Peptide Boronate Derivatives as Histone Deacetylase and Proteasome Dual Inhibitors for Overcoming Bortezomib Resistance of Multiple Myeloma.,  63  (9): [PMID:32267687] [10.1021/acs.jmedchem.9b02161]

Source